Sleep impairment and reduced interneuron excitability in a mouse model of Dravet Syndrome

Neurobiology of Disease
Franck KalumeWilliam A Catterall

Abstract

Dravet Syndrome (DS) is caused by heterozygous loss-of-function mutations in voltage-gated sodium channel NaV1.1. Our mouse genetic model of DS recapitulates its severe seizures and premature death. Sleep disturbance is common in DS, but its mechanism is unknown. Electroencephalographic studies revealed abnormal sleep in DS mice, including reduced delta wave power, reduced sleep spindles, increased brief wakes, and numerous interictal spikes in Non-Rapid-Eye-Movement sleep. Theta power was reduced in Rapid-Eye-Movement sleep. Mice with NaV1.1 deleted specifically in forebrain interneurons exhibited similar sleep pathology to DS mice, but without changes in circadian rhythm. Sleep architecture depends on oscillatory activity in the thalamocortical network generated by excitatory neurons in the ventrobasal nucleus (VBN) of the thalamus and inhibitory GABAergic neurons in the reticular nucleus of the thalamus (RNT). Whole-cell NaV current was reduced in GABAergic RNT neurons but not in VBN neurons. Rebound firing of action potentials following hyperpolarization, the signature firing pattern of RNT neurons during sleep, was also reduced. These results demonstrate imbalance of excitatory vs. inhibitory neurons in this circuit. As pr...Continue Reading

References

Jan 1, 1997·Annual Review of Neuroscience·D A McCormick, T Bal
May 19, 2001·American Journal of Human Genetics·L ClaesP De Jonghe
Nov 9, 2002·Journal of Neurophysiology·Vladyslav V VyazovskiyIrene Tobler
May 20, 2003·Human Mutation·Lieve ClaesPeter De Jonghe
Oct 7, 2003·Epilepsy & Behavior : E&B·Carl W Bazil
Jan 29, 2005·Proceedings of the National Academy of Sciences of the United States of America·Matthew P AndersonSusumu Tonegawa
Mar 24, 2005·Progress in Neurobiology·Pablo Fuentealba, Mircea Steriade
Jun 2, 2005·Trends in Neurosciences·Mircea Steriade
Jun 18, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·S J M Smith
Mar 24, 2006·Journal of Neurophysiology·Rodolfo R Llinás, Mircea Steriade
Aug 15, 2006·Developmental Medicine and Child Neurology·Kathleen J NolanPeter R Camfield
Apr 3, 2007·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Eishi AsanoHarry T Chugani
May 29, 2007·Trends in Neurosciences·Edward O Mann, Ole Paulsen
Jun 1, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ikuo OgiwaraKazuhiro Yamakawa
Oct 11, 2007·BMC Biology·Christopher L DouglasChiara Cirelli
Oct 12, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Franck KalumeWilliam A Catterall
May 23, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Felipe EspinosaRolf H Joho
Nov 26, 2008·Molecular and Cellular Neurosciences·Gregory B PotterJohn L R Rubenstein
Mar 14, 2009·The Neurologist·Rodrigo RocamoraJavier Salas-Puig
Feb 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·John C OakleyWilliam A Catterall
Jul 14, 2010·Journal of the Neurological Sciences·Gabriela MatosSergio Tufik
Jul 20, 2010·Nature Neuroscience·Attila LosonczyJeffrey C Magee
Jan 10, 2012·Proceedings of the National Academy of Sciences of the United States of America·Sung HanHoracio O de la Iglesia
Aug 22, 2012·Proceedings of the National Academy of Sciences of the United States of America·Christine S CheahWilliam A Catterall
Mar 26, 2013·The Journal of Clinical Investigation·Franck KalumeWilliam A Catterall
Jul 16, 2014·Proceedings of the National Academy of Sciences of the United States of America·Chao TaiWilliam A Catterall

❮ Previous
Next ❯

Citations

Nov 8, 2016·Seizure : the Journal of the British Epilepsy Association·Svetlana Gataullina, Olivier Dulac
Nov 8, 2017·Developmental Medicine and Child Neurology·Shane H LicheniIngrid E Scheffer
Oct 5, 2017·Proceedings of the National Academy of Sciences of the United States of America·Joshua S KaplanRuth E Westenbroek
Nov 19, 2018·Nature Reviews. Neurology·Scott T Demarest, Amy Brooks-Kayal
Mar 28, 2020·Journal of Neuroscience Research·Taylor WintlerLucia Peixoto
Sep 19, 2019·Epilepsy Currents·Rui Li, Gordon F Buchanan
Jul 28, 2020·Frontiers in Neurology·Christopher J ReThomas N Ferraro
Aug 15, 2020·Frontiers in Neurology·Cenglin XuZhong Chen
Jun 8, 2017·Neurochemical Research·William A Catterall
Sep 1, 2019·Pharmacological Reviews·Nicholas DenommeGeorge A Mashour
Feb 19, 2016·Journal of Neurophysiology·Michael A Hajek, Gordon F Buchanan
Apr 16, 2019·Frontiers in Neurology·Frida A TeranGeorge B Richerson
Jul 28, 2019·Proceedings of the National Academy of Sciences of the United States of America·Rachael E SteinWilliam A Catterall
Jan 28, 2021·The Journal of Physiology·Benton S PurnellGordon F Buchanan
Jan 4, 2019·Cell Reports·Stefanie Ritter-MakinsonJeanne T Paz
Aug 21, 2018·Current Opinion in Physiology·William A Catterall
Apr 1, 2021·Epilepsy Currents·Gordon F BuchananMilena K Pavlova
Mar 27, 2021·Physiological Reviews·Massimo MantegazzaWilliam A Catterall
Jun 19, 2021·Neurobiology of Disease·Nina MiljanovicHeidrun Potschka
Aug 28, 2021·International Journal of Molecular Sciences·Parthena MartinBradley S Galer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxia

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.

Autism

Autism spectrum disorder is associated with challenges with social skills, repetitive behaviors, and often accompanied by sensory sensitivities and medical issues. Here is the latest research on autism.

Autism: Treatment Targets

The absence of effective treatments for autism are due to the high clinical and genetic heterogeneity between affected individuals, restricted knowledge of the underlying pathophysiological mechanisms, and the lack of reliable diagnostic biomarkers. Identification of more homogenous biological subgroups is therefore essential for the development of novel treatments based on the molecular mechanisms underpinning autism and autism spectrum disorders. Find the latest research on autism treatment targets here.